| ★ 01.11.2026 11:15 UTC | GSK (LSE:GSK) Wins FDA Nod For Jemperli As ESMO Data Builds Oncology Case | Simply Wall St. |
| ★ 29.10.2026 10:01 UTC | Chiesi Group appoints Paolo Paoletti to its Board of Directors | Business Wire |
| ★ 29.10.2026 08:23 UTC | GSK (LSE:GSK) Shares Dropped, So What Is Behind The Latest Attention? | Simply Wall St. |
| ★ 28.10.2026 18:36 UTC | Glaxo: Q3 Earnings Snapshot | Associated Press |
| ★ 28.10.2026 18:04 UTC | What GSK (GSK) Said on Its Q3 Earnings Call | MarketBeat |
| ★ 28.10.2026 15:58 UTC | GSK Fumbles On Vaccines, HIV — Reversing An 11% Pre-Earnings Run | Investor's Business Daily |
| ★ 28.10.2026 14:15 UTC | What GSK Needs to Do After Weak Vaccine Sales Spoil an Earnings Beat | Barrons.com |
| ★ 28.10.2026 10:10 UTC | GSK (GSK) Q3 Earnings and Revenues Beat Estimates ▲ Earnings beat | Zacks |
| ★ 28.10.2026 08:59 UTC | Vaccines worries hit GSK | Proactive |
| ★ 28.10.2026 08:13 UTC | GSK beats Q3 profit estimates, guidance reaffirmed; shares dip ▲ Earnings beat | Investing.com |
| ★ 28.10.2026 07:37 UTC | GSK keeps guidance as specialty drugs power sales, but £328m restructuring charge dents profit ◆ Layoffs | Proactive |
| ★ 27.10.2026 18:04 UTC | GSK Showcases Strong Oncology Pipeline Data at ESMO Investor Update | MarketBeat |
| ★ 27.10.2026 14:50 UTC | Gilead to Report Q3 Earnings: How Should You Play the Stock Now? | Zacks |
| ★ 27.10.2026 09:08 UTC | What Could GSK (LSE:GSK) Oncology Progress Mean For Investors? | Simply Wall St. |
| ★ 24.10.2026 15:08 UTC | Can Specialty Meds Offset GSK’s $2.2B Legal Charges and Sizzling R&D Setbacks on Oct. 28? | 24/7 Wall St. |
| ★ 23.10.2026 07:15 UTC | GSK (LSE:GSK) Secures Ex China Rights To KRAS EGFR Cancer Drug | Simply Wall St. |
| 29.10.2026 15:23 UTC | GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth? | Zacks |
| 28.10.2026 20:19 UTC | Genmab Stock Surges to Record High After Stunning Cancer Drug Results | Barrons.com |
| 28.10.2026 14:45 UTC | GSK Q3 Earnings Top Mark, Stock Down on Soft Vaccines Sales | Zacks |
StockAnalyzer